The NFL and the NFL Players Association (NFLPA) have confirmed they are conducting a joint review regarding the medical handling of Philadelphia Eagles quarterback Jalen Hurts’ blood clot diagnosis. This procedural investigation is standard practice when questions arise concerning the application of league-mandated health and safety protocols for players.

At the center of the review is the timeline and communication process that occurred once the medical condition was identified. While the league and the union have not released specific details regarding potential lapses, the inquiry is focused on whether the medical staff and team officials adhered to the collective bargaining agreement’s requirements for player health reporting and treatment oversight.

Currently, there is no public indication of disciplinary action or specific findings. The review process is intended to ensure that the medical staff provided the necessary care and that the player’s health status was managed in accordance with league standards. Both the NFL and the NFLPA have committed to transparency throughout the process, though neither party has provided a definitive timeline for when the results of the review will be made public. The Eagles organization has stated it is cooperating fully with the investigation, emphasizing that player safety remains the primary priority. As the situation develops, the league is expected to evaluate whether any changes to existing medical protocols are necessary to prevent similar issues in the future.